Biblio

Export 391 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is O  [Clear All Filters]
Journal Article
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
C. Akiba, Nakajima, M., Miyajima, M., Ogino, I., Motoi, Y., Kawamura, K., Adachi, S., Kondo, A., Sugano, H., Tokuda, T., Irie, K., and Arai, H., Change of Amyloid-β 1-42 Toxic Conformer Ratio After Cerebrospinal Fluid Diversion Predicts Long-Term Cognitive Outcome in Patients with Idiopathic Normal Pressure Hydrocephalus., J Alzheimers Dis, vol. 63, no. 3, pp. 989-1002, 2018.
J. R. Hall, Wiechmann, A., Johnson, L. A., Edwards, M., and O'Bryant, S. E., Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints., J Alzheimers Dis, vol. 61, no. 4, pp. 1485-1492, 2018.
A. E. Villarreal, Grajales, S., O'Bryant, S. E., Edwards, M., López, L., Montalván, A., and Britton, G. B., Characterization of Alzheimer's Disease and Mild Cognitive Impairment in Older Adults in Panama., J Alzheimers Dis, vol. 54, no. 3, pp. 897-901, 2016.
S. E. O'Bryant, Petersen, M., Hall, J., Johnson, L. A., Barber, R., Phillips, N., Braskie, M. N., Yaffe, K., Rissman, R., and Toga, A., Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites., J Alzheimers Dis, vol. 90, no. 2, pp. 905-915, 2022.
Y. Zhai, Yamashita, T., Nakano, Y., Sun, Z., Shang, J., Feng, T., Morihara, R., Fukui, Y., Ohta, Y., Hishikawa, N., and Abe, K., Chronic Cerebral Hypoperfusion Accelerates Alzheimer's Disease Pathology with Cerebrovascular Remodeling in a Novel Mouse Model., J Alzheimers Dis, vol. 53, no. 3, pp. 893-905, 2016.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
L. L. Law, Schultz, S. A., Boots, E. A., Einerson, J. A., Dougherty, R. J., Oh, J. M., Korcarz, C. E., Edwards, D. F., Koscik, R. L., N Dowling, M., Gallagher, C. L., Bendlin, B. B., Carlsson, C. M., Asthana, S., Hermann, B. P., Sager, M. A., Johnson, S. C., Cook, D. B., Stein, J. H., and Okonkwo, O. C., Chronotropic Response and Cognitive Function in a Cohort at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 56, no. 1, pp. 351-359, 2017.
L. S. Nidadavolu, Feger, D., Wu, Y., Grodstein, F., Gross, A. L., Bennett, D. A., Walston, J. D., Oh, E. S., and Abadir, P. M., Circulating Cell-Free Genomic DNA Is Associated with an Increased Risk of Dementia and with Change in Cognitive and Physical Function., J Alzheimers Dis, vol. 89, no. 4, pp. 1233-1240, 2022.
H. Zong Ying Wu, Ong, K. Leung, Seeher, K., Armstrong, N. J., Thalamuthu, A., Brodaty, H., Sachdev, P., and Mather, K., Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 49, no. 3, pp. 755-66, 2016.
M. C. de Olive Otto, H Y Wu, J., Thacker, E. L., Lai, H. Tsz Mung, Lemaitre, R. N., Padhye, N., Song, X., King, I. B., Lopez, O., Siscovick, D. S., and Mozaffarian, D., Circulating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older Adults., J Alzheimers Dis, vol. 95, no. 3, pp. 965-979, 2023.
K. Matsuzono, Yamashita, T., Ohta, Y., Hishikawa, N., Sato, K., Kono, S., Deguchi, K., Nakano, Y., and Abe, K., Clinical Benefits for Older Alzheimer's Disease Patients: Okayama Late Dementia Study (OLDS)., J Alzheimers Dis, vol. 46, no. 3, pp. 687-93, 2015.
K. Brueggen, Kasper, E., Ochmann, S., Pfaff, H., Webel, S., Schneider, W., and Teipel, S., Cognitive Rehabilitation in Alzheimer's Disease: A Controlled Intervention Trial., J Alzheimers Dis, vol. 57, no. 4, pp. 1315-1324, 2017.
C. O'Hare, Kenny, R. - A., Aizenstein, H., Boudreau, R., Newman, A., Launer, L., Satterfield, S., Yaffe, K., and Rosano, C., Cognitive Status, Gray Matter Atrophy, and Lower Orthostatic Blood Pressure in Older Adults., J Alzheimers Dis, vol. 57, no. 4, pp. 1239-1250, 2017.
E. - L. Kallio, Öhman, H., Kautiainen, H., Hietanen, M., and Pitkälä, K., Cognitive Training Interventions for Patients with Alzheimer's Disease: A Systematic Review., J Alzheimers Dis, vol. 56, no. 4, pp. 1349-1372, 2017.
S. Beesley, Olcese, J., Saunders, C., and Bienkiewicz, E. A., Combinatorial Treatment Effects in a Cell Culture Model of Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 3, pp. 1155-1166, 2017.
M. Petersen, Hall, J., Parsons, T., Johnson, L., and O'Bryant, S., Combining Select Blood-Based Biomarkers with Neuropsychological Assessment to Detect Mild Cognitive Impairment among Mexican Americans., J Alzheimers Dis, vol. 75, no. 3, pp. 739-750, 2020.
L. A. Johnson, Gamboa, A., Vintimilla, R., Cheatwood, A. J., Grant, A., Trivedi, A., Edwards, M., Hall, J. R., and O'Bryant, S. E., Comorbid Depression and Diabetes as a Risk for Mild Cognitive Impairment and Alzheimer's Disease in Elderly Mexican Americans., J Alzheimers Dis, vol. 47, no. 1, pp. 129-36, 2015.
R. O'Caoimh, Gao, Y., Svendovski, A., Gallagher, P., Eustace, J., and D Molloy, W., Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia., J Alzheimers Dis, vol. 57, no. 1, pp. 123-133, 2017.
N. Lelental, Brandner, S., Kofanova, O., Blennow, K., Zetterberg, H., Andreasson, U., Engelborghs, S., Mroczko, B., Gabryelewicz, T., Teunissen, C., Mollenhauer, B., Parnetti, L., Chiasserini, D., Molinuevo, J. Luis, Perret-Liaudet, A., Verbeek, M. M., Andreasen, N., Brosseron, F., Bahl, J. M. C., Herukka, S. - K., Hausner, L., Frölich, L., Labonte, A., Poirier, J., Miller, A. - M., Zilka, N., Kovacech, B., Urbani, A., Suardi, S., Oliveira, C., Baldeiras, I., Dubois, B., Rot, U., Lehmann, S., Skinningsrud, A., Betsou, F., Wiltfang, J., Gkatzima, O., Winblad, B., Buchfelder, M., Kornhuber, J., and Lewczuk, P., Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics., J Alzheimers Dis, vol. 52, no. 1, pp. 51-64, 2016.
P. N. Tariot, Braeckman, R., and Oh, C., Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil., J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
C. Pieternell van Buuren, van der Steen, J. Theodora, Olthof-Nefkens, M., Bakker, C., Koopmans, R. Theodorus, Perry, M., and Kalf, J. Gezina, The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model., J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
F. Oluwasegun Ishabiyi, Ogidi, J. Okwudirich, Olukade, B. Adejoke, Amorha, C. Christabel, El-Sharkawy, L. Y., Okolo, C. Calistus, Adeniyi, T. Mary, Atasie, N. Hope, Ibrahim, A., and Balogun, T. Adewale, Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.

Pages